ARQT Q1 2025 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$66M+32.8% YoY

Gross Profit

$57M86.6% margin

Operating Income

-$25M-37.3% margin

Net Income

-$25M-38.1% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-7.7%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$31M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$344M

Total Liabilities

$201M

Stockholders' Equity

$143M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$50M	+32.8%
Gross Profit	$57M	$46M	+23.1%
Operating Income	-$25M	-$32M	+22.4%
Net Income	-$25M	-$35M	+29.2%